Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting-Reference-Cited by-同舟云学术

Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting

Published:2018-05 Issue:5 Volume:73 Page:715-723
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Luo Jun,Attard Gerhardt,Balk Steven P.,Bevan Charlotte,Burnstein Kerry,Cato Laura,Cherkasov Artem,De Bono Johann S.,Dong Yan,Gao Allen C.,Gleave Martin,Heemers Hannelore,Kanayama Mayuko,Kittler Ralf,Lang Joshua M.,Lee Richard J.,Logothetis Christopher J.,Matusik Robert,Plymate Stephen,Sawyers Charles L.,Selth Luke A.,Soule Howard,Tilley Wayne,Weigel Nancy L.,Zoubeidi Amina,Dehm Scott M.,Raj Ganesh V.

Publisher

Elsevier BV

Subject

Urology

Reference60 articles.

1. Enzalutamide in metastatic prostate cancer before chemotherapy;Beer;N Engl J Med,2014

2. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011

3. Abiraterone in metastatic prostate cancer without previous chemotherapy;Ryan;N Engl J Med,2013

4. Increased survival with enzalutamide in prostate cancer after chemotherapy;Scher;N Engl J Med,2012

5. Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level;Karantanos;Eur Urol,2015

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure–Activity Relationship (SAR) Studies of Novel Monovalent AR/AR-V7 Dual Degraders with Potent Efficacy against Advanced Prostate Cancer;Journal of Medicinal Chemistry;2024-03-21

2. The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide;Clinical Cancer Research;2024-01-18

3. Discovery of the First-in-Class RORγ Covalent Inhibitors for Treatment of Castration-Resistant Prostate Cancer;Journal of Medicinal Chemistry;2024-01-16

4. Therapeutic Approaches to Targeting Androgen Receptor Splice Variants;Cells;2024-01-04

5. The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancer;Journal of Clinical Investigation;2023-11-15